Authors: RATAIN MJ MICK R JANISCH L BEREZIN F SCHILSKY RL VOGELZANG NJ KUT M

Citation: Mj. Ratain et al., INDIVIDUALIZED DOSING OF AMONAFIDE BASED ON A PHARMACODYNAMIC MODEL INCORPORATING ACETYLATOR PHENOTYPE AND GENDER, Pharmacogenetics, 6(1), 1996, pp. 93-101

Authors: VOGELZANG NJ MICK R JANISCH L BEREZIN F SCHILSKY RL RATAIN MJ

Citation: Nj. Vogelzang et al., PHASE-I AND PHARMACOKINETIC STUDY OF A NEW ANTINEOPLASTIC AGENT - PYRAZINE DIAZOHYDROXIDE (NSC-361456), Cancer research, 54(1), 1994, pp. 114-119

Authors: VOKES EE DOLAN ME KRISHNASAMY S MICK R RATAIN MJ BEREZIN F BRACHMAN D WHITMAN G SCHILSKY RL CHARETTE J WEICHSELBAUM RR DOHRMANN GJ HEKMATPANAH J

Citation: Ee. Vokes et al., 5-FLUOROURACIL, HYDROXYUREA AND ESCALATING DOSES OF IODODEOXYURIDINE WITH CONCOMITANT RADIOTHERAPY FOR MALIGNANT GLIOMAS - A CLINICAL AND PHARMACOLOGICAL ANALYSIS, Annals of oncology, 4(7), 1993, pp. 591-595

Authors: RATAIN MJ MICK R BEREZIN F JANISCH L SCHILSKY RL VOGELZANG NJ LANE LB

Citation: Mj. Ratain et al., PHASE-I STUDY OF AMONAFIDE DOSING BASED ON ACETYLATOR PHENOTYPE, Cancer research, 53(10), 1993, pp. 2304-2308